The journey from a promising chemical structure to a marketable drug is a complex one, heavily reliant on the availability of high-quality pharmaceutical intermediates. NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to supporting this critical phase of drug development by providing essential compounds like 2-Bromo-5-methoxybenzoic Acid (CAS 22921-68-2).

2-Bromo-5-methoxybenzoic Acid serves as a pivotal intermediate, particularly in the synthesis of sophisticated pharmaceutical agents. Its structure is well-suited for incorporating specific functionalities that are often required in molecules designed to interact with biological targets. For instance, the compound’s utility in synthesizing benzylisothioureas, which are known potent divalent metal transporter 1 (DMT1) inhibitors, highlights its direct contribution to therapeutic advancements. DMT1 is implicated in various physiological processes, and compounds that can modulate its activity are of significant interest in treating conditions related to metal ion dysregulation.

Furthermore, the application of 2-bromo-5-methoxybenzoic acid in the preparation of urolithin derivatives is another testament to its value. Urolithins are metabolites of ellagitannins and possess a range of beneficial biological activities, including antioxidant, anti-inflammatory, and cardioprotective effects. The ability to efficiently synthesize these compounds using reliable pharmaceutical intermediates like this benzoic acid derivative is crucial for further research and potential clinical applications.

Companies actively engaged in drug discovery often need to buy chemical compounds that offer predictable reactivity and high purity. NINGBO INNO PHARMCHEM CO.,LTD. ensures that its 2-bromo-5-methoxybenzoic acid meets these rigorous demands. By providing a consistent and high-quality supply of this intermediate, we enable pharmaceutical companies and research institutions to streamline their synthetic routes and accelerate their development timelines. The CAS number 22921-68-2 acts as a universally recognized identifier for this vital compound.

The strategic positioning of the bromine atom and the methoxy group on the benzoic acid core allows for selective chemical modifications. This is a key consideration for medicinal chemists who are designing molecules with precise pharmacological profiles. The compound’s inherent reactivity facilitates the introduction of further complexity, leading to advanced drug candidates. For bulk requirements or specialized needs, NINGBO INNO PHARMCHEM CO.,LTD. is a trusted partner for sourcing this indispensable pharmaceutical intermediate.

In conclusion, 2-Bromo-5-methoxybenzoic Acid is an indispensable component in the modern pharmaceutical intermediate supply chain. Its confirmed role in developing critical therapeutic agents, such as DMT1 inhibitors and urolithin derivatives, underscores its importance. NINGBO INNO PHARMCHEM CO.,LTD. remains committed to providing researchers and manufacturers with this high-quality chemical, thereby contributing to the advancement of global health through innovative drug development.